Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Polo-Like Kinase 1 as a Potential Therapeutic Target for Osteosarcoma

Author(s): Li Cheng, Chongchong Wang and Juehua Jing

Volume 21, Issue 10, 2015

Page: [1347 - 1350] Pages: 4

DOI: 10.2174/1381612820999141029162811

Price: $65

Abstract

Osteosarcoma is the most common primary bone malignancy of adolescents and young adults. Existing treatment options and surgical intervention are unable to effectively manage this tumor. Therefore, novel mechanism-based targets and strategies need to be rationally established to strive for improvement in the survival of patients diagnosed with osteosarcoma. The serine/threonine kinases Polo-like kinase (Plk) 1 is a key regulator of cell division in eukaryotic cells. Plk1 gene and protein expression has been proposed as a new prognostic marker for many types of malignancies, and Plk1 is a potential target for cancer therapy. In this review, we shall discuss the studies which indicate that Plk1 could be an excellent target for the treatment of osteosarcoma.

Keywords: Plk1, osteosarcoma, cancer, therapy, target.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy